Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/15/2026

Buspirone Dosing Guidelines

Introduction to Buspirone Dosing

  • The American Academy of Family Physicians recommends a maximum dose for buspirone of 60 mg per day, typically divided into two or three doses, though doses up to 90 mg per day have been studied and found safe in clinical trials 1
  • The initial dose of buspirone is 5 mg twice daily, as recommended by the American Academy of Family Physicians 1
  • The maximum recommended dose of buspirone is 20 mg three times daily, which is a total daily dose of 60 mg, according to the American Academy of Family Physicians 1

Dosing Schedule and Titration

  • The American Academy of Family Physicians suggests that buspirone can be administered as either twice-daily or three-times-daily regimens with equivalent safety profiles, and the standard maximum of 60 mg/day can be given as either 20 mg TID or 30 mg BID 1
  • Clinical efficacy of buspirone typically emerges within 2-4 weeks, though onset can range from 5-29 days, as reported by the American Academy of Family Physicians 1
  • The American Academy of Family Physicians recommends that doses of buspirone should be increased gradually using increments of the initial dose every 5-7 days until therapeutic benefit or significant side effects occur 1

Evidence‑Based Recommendations for 2.5 mg Buspirone Use

Geriatric and Frail Patients

  • Initiating therapy with a 2.5 mg dose of buspirone is advised for older or frail adults, with gradual titration based on clinical response to enhance safety. 2
  • In studies of elderly individuals (≥ 65 years) receiving the standard 15 mg/day regimen, efficacy and safety were comparable to younger cohorts; however, starting at 2.5 mg provides an additional safety margin for frail patients. 2

Targeted Temperature Management (Anti‑Shivering)

  • Buspirone can be employed as an adjunctive anti‑shivering agent during targeted temperature management after cardiac arrest; the guideline notes its preventive use, synergistic interaction with other anti‑shivering drugs, and a potential to lower seizure threshold. 3

Initial Titration Protocol

  • The recommended starting regimen for low‑dose therapy is 2.5 mg administered twice daily, with dose increments considered after 5–7 days if tolerated. 2